This could be attributed to higher IL-13 levels in patients with severe COVID19 [26].IL-13 is a critical TH2 cytokine linked to atopic dermatitis exacerbations, which could explain the link between severe COVID-19 infection and worsening of atopic dermatitis control/severity [27]. Here, IL13 is linked to COVID-19.